NCT03992625 Clinical Outcomes for Deep Brain Stimulation
| NCT ID | NCT03992625 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Washington University School of Medicine |
| Condition | Parkinson Disease |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,000 participants |
| Start Date | 2011-01-03 |
| Primary Completion | 2030-01-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,000 participants in total. It began in 2011-01-03 with a primary completion date of 2030-01-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The object of this study is to longitudinally collect clinical outcomes of patients receiving deep brain stimulation for movement disorders with the objective of making retrospective comparisons and tracking of risks, benefits, and complications.
Eligibility Criteria
Inclusion Criteria: * Levodopa responsive Parkinson disease OR * Medically refractory Essential Tremor OR * Medically refractory Dystonia Exclusion Criteria: * Dementia (Mattis Dementia Rating Scale \<130) * Structural abnormalities precluding intracranial surgery
Contact & Investigator
Mwiza Ushe, M.D.
PRINCIPAL INVESTIGATOR
Washington University School of Medicine
Frequently Asked Questions
Who can join the NCT03992625 clinical trial?
This trial is open to participants of all sexes, studying Parkinson Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03992625 currently recruiting?
Yes, NCT03992625 is actively recruiting participants. Contact the research team at ushem@wustl.edu for enrollment information.
Where is the NCT03992625 trial being conducted?
This trial is being conducted at St Louis, United States.
Who is sponsoring the NCT03992625 clinical trial?
NCT03992625 is sponsored by Washington University School of Medicine. The principal investigator is Mwiza Ushe, M.D. at Washington University School of Medicine. The trial plans to enroll 1,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.